期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Laparoscopic surgery for gallbladder cancer:is skepticism still justified?
1
作者 Benedetto Ielpo Patricia Sanchez-Velazquez +3 位作者 Gemma Vellalta Alberto Garcia-Picazo Simone Cremona fernando burdio 《Hepatobiliary Surgery and Nutrition》 2025年第5期892-894,共3页
We’ve read with great interest the systematic review and meta-analysis by Li et al.recently published in HepatoBiliary Surgery and Nutrition,which compares open versus laparoscopic(LS)resection for gallbladder cancer... We’ve read with great interest the systematic review and meta-analysis by Li et al.recently published in HepatoBiliary Surgery and Nutrition,which compares open versus laparoscopic(LS)resection for gallbladder cancer(GBC)(1).This is a hot topic in the surgical community,especially for two major reasons:the growing tendency among the new generation of surgeons to adopt minimally invasive techniques,and the increasing proportion of potentially resectable GBC diagnoses,thanks to advances in imaging and diagnostics(2). 展开更多
关键词 Gallbladder cancer(GBC) LAPAROSCOPY minimally invasive
原文传递
A critical review of pancreatectomy with concomitant superior mesenteric artery resection and intestinal autotransplantation
2
作者 Benedetto Ielpo Patricia Sánchez-Velázquez +2 位作者 Gemma Vellalta Mauro Podda fernando burdio 《Hepatobiliary Surgery and Nutrition》 SCIE 2023年第5期756-758,共3页
We have read with great interest the study by Liang et al.addressing the role of radical resection combined with intestinal autotransplantation for locally advanced pancreatic cancer after neoadjuvant therapy(1).The s... We have read with great interest the study by Liang et al.addressing the role of radical resection combined with intestinal autotransplantation for locally advanced pancreatic cancer after neoadjuvant therapy(1).The study may attract the attention of the pancreato-biliary oncological and surgical community. 展开更多
关键词 Pancreatic cancer arterial resection neoadjuvant treatment intestinal autotransplantation
原文传递
Pancreatectomy with concomitant portal vein resection in the current neoadjuvant era
3
作者 Benedetto Ielpo fernando burdio +1 位作者 Ana Martinez Patricia Sanchez-Velazquez 《Hepatobiliary Surgery and Nutrition》 SCIE 2022年第2期295-298,共4页
I’ve read with great interest the paper of Machairas et al.(1)which is of great interest for the oncological and surgical community.Pancreatic adenocarcinoma(PDAC)is still considered a malignancy with an extremely po... I’ve read with great interest the paper of Machairas et al.(1)which is of great interest for the oncological and surgical community.Pancreatic adenocarcinoma(PDAC)is still considered a malignancy with an extremely poor prognosis,being currently the 4th cause of death for cancer and,according to the Global Cancer Statistics in the next decade,it may ascend up to the third cause of death(2).During the last decades,there have been great efforts to improve survival of potentially resectable pancreatic cancer through several improvements.Firstly,the selection of patients:newer preoperative studies have been able to select those patients that might really benefit from resection.Secondly,the surgical procedure itself improved its outcome:proper mesopancreatic dissection and lymphadenectomy,superior mesenteric artery approach and vascular resection have been able to enhance the R0 resection rate with acceptable morbidity(3).Finally,newer chemotherapies regimens have been introduced,as well,with relevant survival improvement(4). 展开更多
关键词 RESECTION DEATH
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部